Table 3.
Characteristics of Chemotherapy [Median- 3 cycles (range: 1–24 cycles)]
Single agent | N=65 | (% of patients) |
Carboplatin | 13 | (20) |
Cisplatin | 8 | (12) |
Gemcitabine | 8 | (12) |
Docetaxel | 6 | ( 9) |
Other | 30 | (46) |
Multiple agents | N=68 | |
Carboplatin/paclitaxel | 26 | (38) |
CHOP/R-CHOP* | 10 | (14) |
Carboplatin/etoposide | 7 | (10) |
Other | 25 | (37) |
Cyclophosphamide, vincristine, adriamycin, predinsone, Rituxmab